Mnaymneh W, Malinin T I, Lackman R D, Hornicek F J, Ghandur-Mnaymneh L
Department of Orthopaedics and Rehabilitation, University of Miami-Jackson Memorial Medical Center, Florida.
Clin Orthop Relat Res. 1994 Jun(303):103-15.
Records were reviewed for 96 patients who received distal femoral osteoarticular allografts to reconstruct femurs after wide resections of benign and malignant bone tumors. Thirteen of these were excluded from the study because of death or local recurrence. The mortality rate for all patients was 11%; for those with osteosarcomas it was 27%. The local recurrence rate was 3%. Eighty-three patients were subjected to further analysis. Their complications included fractures (14%), nonunions (12%), arthritis (10%), instability (7%), infections (6%), and resorption (6%). There was a significant difference in nonunion and infection rates between patients who received chemotherapy and those who did not. In the chemotherapy group, the infection rate was 13% versus 2% in the non-chemotherapy group. Nonunion rates were 23% versus 6% respectively. The differences in all other complication rates were not statistically significant. In patients not receiving chemotherapy (n = 53), final results were good or excellent in 70%, fair in 26%, and poor in 4%. In patients receiving chemotherapy (n = 30), final results were good or excellent in 53%, fair in 37%, and poor in 10%.
对96例接受股骨远端骨关节异体移植以重建良性和恶性骨肿瘤广泛切除术后股骨的患者的记录进行了回顾。其中13例因死亡或局部复发被排除在研究之外。所有患者的死亡率为11%;骨肉瘤患者的死亡率为27%。局部复发率为3%。83例患者接受了进一步分析。他们的并发症包括骨折(14%)、骨不连(12%)、关节炎(10%)、不稳定(7%)、感染(6%)和吸收(6%)。接受化疗的患者与未接受化疗的患者在骨不连和感染率方面存在显著差异。化疗组的感染率为13%,而非化疗组为2%。骨不连率分别为23%和6%。所有其他并发症发生率的差异无统计学意义。在未接受化疗的患者(n = 53)中,最终结果为良好或优秀的占70%,中等的占26%,差的占4%。在接受化疗的患者(n = 30)中,最终结果为良好或优秀的占53%,中等的占37%,差的占10%。